Half of the female transgenic mice harbouring human papillomavirus type 16 (HPV-16) E6-E7 genes under control of the mouse mammary tumour virus promoter, developed malignant tumours, including salivary gland carcinomas, lymphomas and skin histiocytomas. Although the E6-E7 genes are aetiological factors for human anogenital carcinoma, the transgenic mice produced no tumours in the anogenital tract. We investigated cytological and histological changes in the anogenital tract of the same transgenic mice. Seventeen (77 %) of 22 transgenic mice developed dysplastic and/or hyperplastic changes in the cervix and vagina. E6-E7 mRNA signals were observed in the genital lesions, while they were not detected in the normal cervices and vaginas of transgenic mice and control mice by RNA in situ hybridization analysis. RNA/PCR analysis using poly(A) + RNA showed that only a fulllength E6-E7 RNA was expressed in three scraped cell samples from dysplasia, whereas full-length and spliced E6-E7 transcripts were in three cell samples from dysplasia/hyperplasia. These results suggest that expression of both E6 and E7 genes ofHPV-16 is important for inducing dysplastic and hyperplastic changes in the genital epithelium.
Introduction
More than 70 types of human papillomavirus (HPV) have been isolated from various warts and carcinoma tissues, and a subset of these viruses is found in the anogenital tract. HPV-16 (Diirst et al., 1983) and -18 (Boshart et al., 1984) are frequently detected in cervical and other genital cancers, and they have been thought to be aetiological factors for these malignant tumours.
The E6-E7 open reading frames (ORFs) of these HPV types are retained and expressed in cervical carcinoma cell lines and cervical carcinoma tissues (Smotkin & Wettstein, 1986; Baker et al., 1987; Shirasawa et al., 1988) , suggesting that the encoded genes are involved in the initiation and/or promotion of these neoplasias (Schwarz et al., 1985; Schneider-G~idicke & Schwartz, 1986) . In support of their apparent involvement in cervical carcinogenesis, the E6 and E7 genes of these HPV types cooperate to immortalize normal human foreskin keratinocytes in vitro (Hawley-Nelson et al., 1989; Mtinger et al., 1989; Hudson et al., 1990) . The human keratinocytes immortalized by E6 and E7 genes of HPV-18 (Hudson et al., 1990) et al., 1992) show an altered differentiation in the raft system, but these immortalized cells do not produce tumours in nude mice. This may mean that the E6 and E7 genes can induce premalignant changes, but are not able to cause the subsequent malignant progression in human keratinocytes. Additional cellular events are necessary for malignant progression of these immortalized cells. On the other hand, in a xenograft model system, the expression of E6-E7 genes of HPV-16 is repressed in an epidermal cyst composed of human keratinocytes immortalized by HPV-16, although it is not repressed in a tumour of carcinoma cells (Dtirst et al., 1991) . Therefore we cannot exclude the possibility that insufficient expression of the E6 and E7 genes in vivo may prevent the immortalized cells from progressing to a malignant tumour.
The transcription patterns of E6-E7 genes of HPV-16 have been extensively studied in carcinoma and dysplastic tissues of the cervix and in cell lines derived from cervical carcinomas. Three types of E6-E7 mRNA have been identified, one of which is a full-length E6-E7 transcript and the others are termed E6*-E7 and E6**-E7, which are spliced in the E60RF. The spliced transcripts are presumed to encode the E7 protein, which is expressed abundantly in carcinomas and cell lines (Smotkin et al., 1989) . In a recent study, the full-length E6-E7 transcript was shown to encode mainly the E6 protein, as the mutation that prevented splicing in E6-E7 mRNA severely reduced the level of E7 protein but increased E6 protein levels (Sedman et al., 1991). Thus, it is important to investigate the transcription pattern as well as the transcription level of E6--E7 genes to study the function of E6 and E7 genes in an in vivo model system.
We have recently established three lines (lines 181,274 and 263) of transgenic mice carrying the E6-E7 genes of HPV-16 (Kondoh et al., 1991) . In that report, the mice of line 181 showed a high incidence of development of testicular tumours, whereas the mice of lines 263 and 274 developed various types of malignant tumour. In the present study, we examined these mice for cytological and histological changes in the cervix and vagina and we have observed dysplasfic and hyperplastic changes of the genital epithelium in many mice of the line 274. Furthermore, we have studied the expression level and pattern of HPV-16 E6-E7 transcripts in those lesions of the cervix and vagina compared with that in the other tumours. We discuss the relationship between expression of these viral genes and the histopathological changes occurring in the neoplastic process.
Methods
Transgenic and non-transgenic mice. The female virgin mice derived from line 274 transgenic mice (Kondoh et aL, 1991) were used in this study. Thirty-seven female mice were obtained from these parental mice. Cellular DNA was extracted from mouse tail tissue and the presence of viral genes was examined by Southern blot analysis with the E6-E7 probe of HPV-16. Twenty-five of the mice carried the transgene of HPV-16 E6-E7 and 12 mice did not. Mice without the transgenes were used as controls. All mice were maintained in an air-conditioned room and supplied with sterile water and aseptic chow. Three mice from each group died of unknown causes during observation, and they are omitted from the subsequent analyses.
Six of 22 transgenic mice were sacrificed from the age of 9 to 13 months when tumours developed, and the other 16 transgenic mice and all eight control mice were killed at the age of 15 months. All sacrificed mice were subsequently autopsied and dissected. The tumour and its counterpart of normal tissues were resected from several mice, and the salivary glands and female reproductive organs were obtained from all mice. These tissue specimens were employed for histopathological and molecular analyses.
Tissue and cell specimens. Tumour and normal tissues were divided into two parts : one for histopathological study, and the other for RNA extraction. Most tissues from the genital organs were used for histopathological study to make an accurate diagnosis. Histological specimens were fixed with 4% buffered paraformaldehyde and 70% ethanol, and were embedded in paraffin. Two sets of serial sections were prepared from these embedded tissues: one was employed for haematoxylin and eosin (HE) staining and the other for RNA-RNA in situ hybridization. The corpus uteri and the cervix/vagina were examined histologically in 22 transgenic mice and eight control mice. At the same time, the oestrous stage in each mouse was determined by morphologies of the endometrial glands and the cervical/vaginal squamous epithelia.
Cervical and vaginal cells were scraped off with a swab from all mice monthly and evaluated for any cytological changes. The cell samples were collected from both cervix and vagina before sacrificing the mice. A part of the sample was used for cytological evaluation and the other part was subjected to RNA extraction by the acid guanidiniumthiocyanate~:hloroform procedure (Chomczynski & Sacchi, 1987) for the subsequent analysis by reverse transcription (RT)-PCR.
The cyto-and histopathological evaluations were carried out independently by two experienced surgical pathologists who were not informed on the status of the samples, i.e. whether they were derived from a transgenic or a control mouse.
RNA in situ hybridization. Paraffin-embedded tissue sections were mounted on poly-L-lysine-coated glass slides and deparaffinized. The slides were then subjected to RNA in situ hybridization with a digoxigenin-labelled RNA probe of HPV-16 E6-E7 genes. The procedure was as described previously (Sasagawa et al., 1992) , with some modifications according to the method of Hirota et al. (1992) .
The DNA fragment of E6~E7 [nucleotides (nt) 104 to 858] of HPV-16, which was obtained by PCR, was subcloned into the Bluescript II plasmid (Stratagene Toyobo). After confirming the orientation of the inserted gene, a digoxigenin-labelled E~E7 riboprobe was produced from the recombinant vector (pBSE6-E7) with a digoxigenin RNA labelling kit according to the manufacturer's instructions (Boehringer Mannheim-Yamanouchi.
Deparaffinized tissue sections were treated with 10lag/ml of proteinase K in 10 mM-Tris-HCl pH 8.0 and 1 mM-EDTA at 37 °C for 30 min, refixed with 4 % paraformaldehyde in PBS for 20 min, rinsed in PBS and treated with 0.2 M-HC1 for inactivation of endogenous alkaline phosphatase. After washing with PBS, they were incubated in 0-1 M-ethanolamine-HC1 pH 8-0 for a few minutes and acetylated with 0.25% acetic anhydride in 0"1 M-triethanolamine pH 8.0 for 10 min. They were then dehydrated in ethanol series and air-dried. Next, 70 pl of hybridization solution was placed on each section, followed by incubation at 45 °C for 16 h in a moist chamber. The hybridization solution contained 50% formamide, 10% dextran sulphate, lx Denhardt's solution, 600 mM-NaC1, 10 mM-Tris-HC1 pH 8.0, 10 mM-DTT, 0"25 % SDS, 200 lag/ml of yeast tRNA, and approximately 0.6 lag/ml of RNA probe. The detection of RNA signals was performed with a digoxigenin-labelled RNA detection kit (Boehringer MannheimYamanouchi) by the previously described procedure (Sasagawa et al., 1992) . Two tissue specimens from each sample were placed on the same glass slide. One was hybridized with the antisense RNA probe and the other with the sense RNA probe.
Northern blot hybridization. The total RNA from each tissue specimen was isolated by the method of Glisin et al. (1973) . Thirty micrograms of total RNA sample was denatured with 50 % formamide and 5 % formaldehyde at 65 °C for 15 min, and separated on a 1% agarose gel containing 5 % formaldehyde in 20 mM-MOPS buffer. The RNA was transferred to a nylon filter (Magna Graph, MSI) in 20 x SSC, and the filter was hybridized with a 32P-labelled HPV-16 E6-E7 DNA probe under highly stringent conditions.
RNA/PCR (RT-PCR) analysis. RT-PCR for HPV-16 E6--E7 genes
and for mouse fl-actin genes was carried out as follows. The E~E7 sequence (nt 104 to 855) was amplified with 5' primer (ATGTTTCA-GGACCCACAGGAG) and 3" primer (TTATGGTTTCTGAGAA-CAGAT). The mouse fl-actin sequence (nt 1242 to 2361) was amplified with 5' primer (ATGGATGACGATATCGCTG) and 3' primer (ATGAGGTAGTCTGTCAGGT). The poly(A) ÷ RNA suspension was prepared as follows: 10 lag of total cellular RNA was suspended in 60 lal of Tris-EDTA (TE) buffer (10 mM-TribHC1 pH 7.5, l mM-EDTA), heated at 65 °C for 5 min and cooled quickly at 4 °C for 3 min, followed by addition of 7.5 gl of 5 M-NaC1 and 15 gl of Oligotex dT 30 (Japan Roche). This mixture of RNA and Oligotex dT 30 was incubated at 37 °C for 5 min, and the complexes of poly(A) ÷ RNA and Oligotex dT 30 were then collected by microcentrifngation (Eppendorf) at 15000 r.p.m, for 1 rain. After two washes with 200 lal of TE buffer and 25 gl of 5 M-NaC1, the complexes were suspended and incubated in 200 gl of TE buffer at 65 °C for 5 rain. The supernatant containing free poly(A) + RNA was collected and subsequently washed twice with phenol~:hloroform solution, and the poly(A) + RNA was then precipitated with 0"3 M-sodium acetate and 500 gl of ethanol. Finally the poly(A) + RNA was suspended in 10 gl of TE buffer.
Each poly(A) + RNA sample was mixed in a total volume of 20 gl of a reaction mixture containing reverse transcription buffer (BRL), 25 units of RNasin (Takara), 1 mM of each of the dNTPs, 35 pM of poly(dT) primer and 200 units of cloned Moloney murine leukaemia virus reverse transcriptase (BRL). The reaction was allowed to proceed for 30 min at 42 °C, and the reverse transcriptase was then inactivated at 95 °C for 5 min. Amplification of cDNA was performed subsequently by adding 80 gl of solution containing 35 pM of each PCR primer, amplification buffer and 2 units of Taq polymerase (Perkin Elmer Cetus). The reaction was subjected to 30 PCR amplification cycles, beginning with DNA denaturation at 94 °C for 1 min, followed by a primer annealing step at 55 °C for 1 rain and an elongation step at 72 °C for 2 min. The final elongation step was prolonged for 7 rain. One-tenth of the amplified PCR product was separated by electrophoresis through a 2% agarose gel. The electrophoresed DNA was subjected to Southern blot hybridization as described previously (Sasagawa et al., 1992) , and autoradiography was performed for a few hours.
Results

Malignant and premalignant lesions in the multiple organs
Malignant tumours were observed in various tissues of 11 (50 %) of the 22 transgenic mice harbouring HPV-16 E6-E7 genes under the MMTV promoter (Kondoh et al., 199 l) . All malignant tumours developed after 9 months of age. Salivary gland carcinoma was observed in eight mice and premalignant lesions (atypical glandular hyperplasia) in three mice. All types of neoplasias arising in this transgenic strain are listed in Table 1 .
Northern blot analysis showed that the HPV-16 E6-E7 mRNAs of 2-3 and 1.7 kb, corresponding to RNA molecules transcribed from the mouse mammary tumour virus and HPV-16 promoters (Kondoh et al., 1991) , were highly expressed in all four types of malignant tumour (lanes 1 to 8 in Fig. 1 ), but faintly or not expressed at all in apparently normal salivary gland (lanes 9 to 12 in Fig.  1 ) and in normal tissues of other organs (data not shown). Signals of the E6-E7 mRNA were also detected in two premalignant tissues and one carcinoma tissue of th e salivary gland by in situ hybridization analysis ( Table  2 ). All of the findings suggest that high expression of the E6-E7 genes is essential for the development of malignant tumours in these transgenic mice.
Cervical and vaginal lesions of the transgenic mice
We evaluated cytological changes in the vaginal smears monthly in all mice derived from line 274. Mild dysplastic cells with dyskeratotic and/or metaplastic cells were observed in three (14 %) of the transgenic mice under the age of 3 months. Mild dysplastic cells were observed in 10 (45 %) and severe dysplastic cells were in three (14 %) of 22 transgenic mice from the age of 12 months. Dysplastic cells were not observed in any control mice w i t h o u t H P V genes, a l t h o u g h dyskeratotic a n d / o r metaplastic changes were seen in some of them. Histologically a b n o r m a l lesions of the uterine cervices a n d v a g i n a s were observed in 17 (77 %) of 21 t r a n s g e n i c mice (Table 1) . O u t of 17 mice, four h a d hyperplastic changes (Fig. 3 a) , eight h a d dysplastic changes (Fig. 3 d) , five h a d b o t h types o f lesion. T h e other five t r a n s g e n i c mice were n o r m a l (Fig. 2a) . Histological diagnosis coincided with that of cytology in each specimen. D e v e l o p m e n t of the genital lesions was n o t associated with t u m o u r f o r m a t i o n in each m o u s e (Table 1) . H y p e r p l a s t i c change was characterized by diffuse p r o l i f e r a t i o n o f basal a n d p a r a b a s a l cells within w i d e n e d epithelial b o u n d a r i e s . H y p e r p l a s t i c lesions were a p p a rently different f r o m t h i c k e n e d n o r m a l epithelia which were observed d u r i n g oestrus (Fig. 2a) . T h e h o r m o n ed e p e n d e n t changes were observed in whole cervical/ v a g i n a l epithelia a n d were rarely a c c o m p a n i e d with hypercellularity, whereas the hyperplastic changes were m o r e localized a n d a c c o m p a n i e d with hypercellularity (Fig. 3a) . Dysplastic change was characterized by a n a b n o r m a l e p i t h e l i u m in which the cellular o r g a n i z a t i o n a n d m a t u r a t i o n were disturbed. It was c o m p o s e d of a b n o r m a l cells possessing a n atypical n u c l e u s e n l a r g e d with coarse a n d dense c h r o m a t i n , a n d m a n y nucleoli (Fig. 3d) . These a b n o r m a l i t i e s were n o t observed in n o r m a l epithelia d u r i n g the whole oestrous cycle (Fig.  2a, c) . A p p a r e n t dysplastic changes were observed in the To examine the localization and intensity of the signals o f E6 and E7 m R N A s in the cervical and vaginal lesions o f transgenic mice, we carried out R N A in situ hybridization. All results are shown in Table 2 and a typical result is d e m o n s t r a t e d in Fig. 2 and Fig. 3 . The E 6 -E 7 transcripts were detected with the antisense E 6 -E 7 R N A probe in six hyperplastic and dysplastic lesions (Fig. 3 b, e and Table 2) . N o signals c o r r e s p o n d i n g to E6 and E7 transcripts were detected with the sense p r o b e (Fig. 3 c, f ) and not in three n o r m a l epithelia (Fig.  2b and Table 2) , although weak signals were detected in some n o r m a l areas adjacent to the dysplasia and the hyperplasia (data not shown). These viral signals were observed in whole epithelial cells but not in the stromal cells (Fig. 3 b, e ).
R T P C R analysis of cervical~vaginal lesions and tumours
W e could not examine whether HPV-16 E 6 -E 7 genes are truly expressed in a b n o r m a l lesions of the cervix and vagina by N o r t h e r n blot analysis, because a sufficient a m o u n t of R N A could not be o b t a i n e d from these a b n o r m a l tissues. Histological diagnosis had coincided with that o f cytology in each specimen. W e therefore examined the expression of HPV-16 E 6 -E 7 genes in the T. Sasagawa and others Table 2 and a typical result is demonstrated in Fig. 4 .
Three types of RT-PCR products, 755 bp, 634 bp and 457 bp, were identified by Southern blot hybridization with the E6-E7 probe (Fig. 4b) . These products appear to represent the full-length E6-E7 transcript (755 bp), the E6*-E7 transcript (634 bp) and the E6**-E7 transcript (457) of HPV-16, respectively (Smotkin et al., 1989) . Only the full-length transcript (FL-E6-E7) was detected in three of seven abnormal scraped cell samples (lanes 4, 5 and 7 in Fig. 4b) . The FL-E6-E7 and E6*-E7 transcripts were detected in three abnormal cell samples (lanes 2 and 3) and the FL-E6-E7, E6*-E7 and E6**-E7 transcript were in one abnormal cell sample (Table 2) . FL-E6-E7 and E6*-E7 were also detected in the one cell line (SiHa) derived from human cervical carcinoma (lane 6), in two premalignant lesions of salivary gland (lanes 13 and 15) and all tumours (lanes 8 to 12). Although the FL-E~E 7 was faint in one genital lesion (lane 2) and one premalignant lesion of salivary gland (lane 13), the band was clearly observed on an overexposed film (data not shown). On the other hand, no bands were detected in four normal scraped cell samples from the transgenic mouse (lanes 1) and control mice (data not shown), although faint E6*-E7 expression was detected in one (lane 14) of two normal tissues of the salivary gland.
The RT-PCR products of mouse fl-actin were used as an internal control to estimate the relative transcription levels of the E6-E7 genes with an image analyser. The intensity of the band on Southern blot film and the ratio of E6-E7 :fl-actin varied greatly among these cell samples ( Fig. 4a and Table 2 ), but the ratio was well correlated with intensity of the signals of the E6-E7 mRNA determined by in situ hybridization (Table 2 ). There is no strong evidence that HPV-16 E6-E7 genes are expressed to a much lesser degree in the cervical/vaginal samples than in human cervical carcinoma cell line and neoplastic lesions of the other organs.
The transcription pattern was quite different between the neoplasia tissues and the cervical and vaginal cell samples. The E6*-E7 was not detected in three of seven abnormal cell samples of the cervices and vaginas, whereas it was detected in all neoplasia samples (Table  2 ). In the cervix/vagina, both full-length and spliced E6-E7 transcripts were detected in three cell samples from dysplasia/hyperplasia and one hyperplasia, whereas only the full-length E6-E7 was detected in three cell samples from dysplasia. The transcripts detected in the scraped cell samples may not be the same as those expressed in dysplasia or hyperplasia tissues. However most of them are presumably derived from dysplastic or hyperplastic cells rather than normal cells, since strong transcription signals were detected mainly in dysplastic or hyperplastic cells rather than in adjacent normal cells by in situ hybridization.
Discussion
It has been reported by different authors that skin neoplasias are induced in transgenic mice expressing the bovine papillomavirus type 1 gene (Lacey et al., 1986) , the HPV-1 gene (Tinsley et al., 1992) and the HPV-16 gene (Lambert et al., 1993) , but our transgenic mice harbouring HPV-16 E6-E7 genes are the first lines to produce cervical and vaginal dysplasia/hyperplasia as well as neoplasia of other organs. The C57BL/6J mouse used in this study is known to be a less susceptible strain for any spontaneous tumour, very rarely forming one under the age of 18 months (Staats, 1976) . In the present study, all tumours of various organs and all genital lesions of the cervix and vagina were observed in the transgenic mice under the age of 15 months, strongly suggesting that they were induced by expression of the transgene.
Dysplastic and hyperplastic changes were observed in the cervix and vagina of 17 of the 22 (77 %) transgenic mice (line 274) carrying HPV-16 E6 and E7 genes. These lesions were not observed in the control mice. In preliminary studies, such histological changes were not apparent in mice of the lines 181 and 263. The type of turnout and the incidence of tumour formation are also different between all these lines (unpublished data). Based on these results, it is suggested that the integration site of the transgene may have some influence on the expression of these HPV genes.
In other model systems using human primary keratinocytes or cervical epithelial cells which allow stratification in a raft system or beneath a skin-muscle flap on mice, immortalized cells transfected with the whole genome of HPV-16 exhibit a dysplastic morphology (McCance et al., 1988; Woodworth et al., 1990) . Recently such morphological changes were observed in immortalized keratinocytes transfected with the E6 and E7 genes of HPV-18 (Mfinger et al., 1989) and HPV-16 (Blanton et al., 1992) in the raft system. However, neither these immortalized lines nor the genital lesions observed in our transgenic mice show any malignant characteristics. All the results suggest that the E6 and E7 genes of the oncogenic HPVs have the ability to induce dysplastic changes, but additional cellular events are necessary for malignant progression of the epithelial cells (Riou et al., 1985; Saxon et al., 1986; Yokota et al., 1989; Miyasaka et al., 1991) .
The expression level, pattern and distribution of E6-E7 mRNAs in the lesions observed in the transgenic mice were examined by RNA in situ hybridization and by RTPCR using poly(A) + RNA. The E6-E7 mRNAs were detected in the dysplastic and hyperplastic lesions of the cervix and vagina as in the premalignant and malignant lesions of the salivary gland. These transcripts were not detected in the normal genital epithelia of transgenic mice (Fig. 2b, 4b and Table 2 ). Expression of the E6-E7 region seems to be essential for development of these lesions in the genital epithelia as well as neoplastic transformation in the salivary glands. The transcription patterns of E6-E7 in the genital lesions were different from the salivary gland neoplasias. Spliced transcript (E6*-E7) was not detected in about half of the analysed cervical and vaginal lesions, whereas it was detected in all premalignant and malignant tissues of the salivary gland, and a cervical cancer cell line SiHa (Fig.  4b and Table 2 ). E6* E7 is presumed to encode mainly the E7 product (Smotkin et al., 1989) , whereas the full-length E6-E7 encodes the E6 product (Sedman et al., 1991) . The E7 protein is known to have an ability to prolong the life span of keratinocytes and can immortalize epithelial cells in vitro. In the present results, both full-length and spliced E6-E7 transcripts were detected in three dysplasia/hyperplasia samples and one hyperplasia, whereas only the full-length E6-E7 transcript was detected in three dysplastic lesions (Table 2) . Thus, the E7 protein may induce hyperplastic growth of the genital epithelium. Our results also suggest that the E6 protein may be necessary for inducing dysplastic changes, because expression of the full-length E6-E7 was observed in three lesions showing dysplastic change alone. The correlations between histological changes of the genital epithelium and the transcription patterns of the E6-E7 genes, are interesting when considering the dissociated functions of E6 and E7 genes in vitro (Yutsudo et al., 1988; Inoue et al., 1994) , but it will be necessary to investigate many more samples and analyse expression of the E6 and E7 proteins in these tissues to determine the functions of the E6 and E7 proteins in vivo.
The hyperplastic changes of the genital epithelia observed in this study may represent premalignant changes in the mouse model system. In previous mouse models in which genital cancer is induced by treatment with chemical carcinogens (Haam & Scarpelli, 1955; Scarpelli & Haam, 1957) , most premalignant lesions show papillary hyperproliferation rather than the atypia seen in the dysplastic lesion. Moreover, most genital carcinomas induced in mice were indicated to be moderately to well-differentiated types, although welldifferentiated types are rare in human cervical carcinoma. We obtained similar results in a model study with the coadministration of a recombinant retrovirus containing HPV-16 E6-E7 genes plus N-methyl-N'-nitro-N-nitroso- guanidine or 12-O-tetradecanoylphorbol 13-acetate into the mouse genitalia (Sasagawa et al., 1992) , and we ascertained that some of the early lesions of these carcinomas were difficult to distinguish from some hyperplastic lesions also induced in these experiments. Although further study is needed to clarify the significance of these pathological findings in the present model system using transgenic mice, we postulate at least that both the E6 and E7 genes of HPV-16 are important for the development of dysplastic and hyperplastic lesions in the cervix and vagina.
The transgenic mouse model system employed in this study is likely to be a useful system for investigating HPV-16 E6-E7 gene functions in vivo, although we have no clear answers as tO why tumours do not develop in the genital epithelia of our transgenic mice. The external stimulation such as wounding reported in the induction of skin carcinoma (Lambert et aI., 1993), or more effective expression of the E6-E7 genes might be necessary for full neoplastic progression of the genital epithelium.
